Skip to main content
. 2016 Aug 17;11:1939–1947. doi: 10.2147/COPD.S104728

Table 2.

Outcome variables at the end of the study

Outcome variables Control N=38 Intervention N=47 P-value
Secondary outcome variables
No of patients with COPD exacerbations with hospitalization or ER visit 20 (52.6%) 19 (40.4%) 0.262
No of patients with COPD exacerbations ER visit 14 (36.8%) 9 (19.1%) 0.068
No of patients with COPD exacerbations hospitalization 16 (42.1%) 12 (25.5%) 0.106
No of patients who needed antibiotics 18 (47.4%) 27 (56.3%) 0.306
No of patients who needed glucocorticoids 17 (44.7%) 18 (37.5%) 0.413
Days of hospital stay due to respiratory cause, mean ± SD 12.4±7.1 9.3±6.4 0.154
All-cause mortality 2 (5.26%) 0 0.191
Primary outcome variables
No COPD exacerbations with hospitalization or A&E visit 52 42
Days at risk 3,801 4,700
Rate of exacerbations with hospitalization or A&E visit, n (range) 1.37 (1.02–1.79) 0.89 (0.64–1.21) 0.049
Rate ratio, n (range) 1.53 (1.01–2.29)

Abbreviation: SD, standard deviation.